The small leucine-rich proteoglycan lumican inhibits melanoma progression

Experimental Cell Research

Volumn 296, Issue 2, 2004, Pages 294-306

  Vuillermoz, Boris ^a   Khoruzhenko, Antonina ^a,c   D'Onofrio, Marie France ^a   Ramont, Laurent ^a   Venteo, Lydie ^b   Perreau, Corinne ^a   Antonicelli, Frank ^a   Maquart, François Xavier ^a   Wegrowski, Yanusz ^a,b  

^a CNRS   (France)

^b UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^c STATE INSTITUTION NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE   (Ukraine)

Author keywords

Anti tumor; CFE; colony forming efficiency; ECM; extracellular matrix; FBS; fetal bovine serum; Invasion; Lumican; Melanoma; Migration; Ni NTA; nickel nitrilotriacetic acid; PBS; phosphate buffered saline; Proteoglycan; SDS PAGE

Indexed keywords

AGAROSE; COMPLEMENTARY DNA; DECORIN; LEUCINE; LUMICAN; PROTEOGLYCAN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; DRUG MECHANISM; EXTRACELLULAR MATRIX; FEMALE; GENETIC TRANSFECTION; IN VIVO STUDY; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE;

BOVINAE;

EID: 2442570675     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2004.02.005     Document Type: Article

References (59)

1. Elder D.E. Skin cancer. Melanoma and other specific nonmelanoma skin cancers. Cancer. 75:1995;245-256
2. Balch C., Houghton A., Soong S.-J.A. Cutaneous Melanoma. 3rd edition:1998;Quality Medical Publishing, St. Louis
3. Barnhill L., Crowson N., Busam K., Granter S. Textbook of Dermatopathology. 1998;McGraw-Hill, New York
4. Suster S. Hyalinizing spindle and epithelioid cell nevus. A study of five cases of a distinctive histologic variant of Spitz's nevus. Am. J. Dermatopathol. 16:1994;593-598
5. Ruiter D., Bogenrieder T., Elder D., Herlyn M. Melanoma-stroma interactions: structural and functional aspects. Lancet Oncol. 3:2002;35-43
6. Iozzo R.V. The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit. Rev. Biochem. Mol. Biol. 32:1997;141-174
7. Danielson K.G., Baribault H., Holmes D.F., Graham H., Kadler K.E., Iozzo R.V. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J. Cell Biol. 136:1997;729-743
8. Xu T., Bianco P., Fisher L.W., Longenecker G., Smith E., Goldstein S., Bonadio J., Boskey A., Heegaard A.M., Sommer B., Satomura K., Dominguez P., Zhao C., Kulkarni A.B., Robey P.G., Young M.F. Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat. Genet. 20:1998;78-82
9. Chakravarti S., Magnuson T., Lass J.H., Jepsen K.J., LaMantia C., Carroll H. Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J. Cell Biol. 141:1998;1277-1286
10. Schmidt G., Robenek H., Harrach B., Glossl J., Nolte V., Hormann H., Richter H., Kresse H. Interaction of small dermatan sulfate proteoglycan from fibroblasts with fibronectin. J. Cell Biol. 104:1987;1683-1691
11. Hassell J.R., Newsome D.A., Krachmer J.H., Rodrigues M.M. Macular corneal dystrophy: failure to synthesize a mature keratan sulfate proteoglycan. Proc. Natl. Acad. Sci. U. S. A. 77:1980;3705-3709
12. Ping Lu Y., Ishiwata T., Asano G. Lumican expression in alpha cells of islets in pancreas and pancreatic cancer cells. J. Pathol. 196:2002;324-330
13. Rada J.A., Cornuet P.K., Hassell J.R. Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins. Exp. Eye Res. 56:1993;635-648
14. Lu Y.P., Ishiwata T., Kawahara K., Watanabe M., Naito Z., Moriyama Y., Sugisaki Y., Asano G. Expression of lumican in human colorectal cancer cells. Pathol. Int. 52:2002;519-526
15. Leygue E., Snell L., Dotzlaw H., Troup S., Hiller-Hitchcock T., Murphy L.C., Roughley P.J., Watson P.H. Lumican and decorin are differentially expressed in human breast carcinoma. J. Pathol. 192:2000;313-320
16. Troup S., Njue C., Kliewer E.V., Parisien M., Roskelley C., Chakravarti S., Roughley P.J., Murphy L.C., Watson P.H. Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin. Cancer Res. 9:2003;207-214
17. Hocking A.M., Shinomura T., McQuillan D.J. Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol. 17:1998;1-19
18. Hildebrand A., Romaris M., Rasmussen L.M., Heinegard D., Twardzik D.R., Border W.A., Ruoslahti E. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem. J. 302(Pt. 2):1994;527-534
19. Nash M.A., Loercher A.E., Freedman R.S. In vitro growth inhibition of ovarian cancer cells by decorin: synergism of action between decorin and carboplatin. Cancer Res. 59:1999;6192-6196
20. Iozzo R.V., Moscatello D.K., McQuillan D.J., Eichstetter I. Decorin is a biological ligand for the epidermal growth factor receptor. J. Biol. Chem. 274:1999;4489-4492
21. Tralhao J.G., Schaefer L., Micegova M., Evaristo C., Schonherr E., Kayal S., Veiga-Fernandes H., Danel C., Iozzo R.V., Kresse H., Lemarchand P. In vivo selective and distant killing of cancer cells using adenovirus-mediated decorin gene transfer. FASEB J. 17:2003;464-466
22. Weber C.K., Sommer G., Michl P., Fensterer H., Weimer M., Gansauge F., Leder G., Adler G., Gress T.M. Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines. Gastroenterology. 121:2001;657-667
23. Chen W.B., Lenschow W., Tiede K., Fischer J.W., Kalthoff H., Ungefroren H. Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells. J. Biol. Chem. 277:2002;36118-36128
24. Grover J., Chen X.N., Korenberg J.R., Roughley P.J. The human lumican gene. Organization, chromosomal location, and expression in articular cartilage. J. Biol. Chem. 270:1995;21942-21949
25. Staal F.J., Roederer M., Herzenberg L.A. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sci. U. S. A. 87:1990;9943-9947
26. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685
27. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254
28. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 76:1979;4350-4354
29. Burg M.A., Grako K.A., Stallcup W.B. Expression of the NG2 proteoglycan enhances the growth and metastatic properties of melanoma cells. J. Cell. Physiol. 177:1998;299-312
30. Kosano H., Kayanuma T., Nishigori H. Stimulation of melanogenesis in murine melanoma cells by 2-mercapto-1-(beta-4-pyridethyl) benzimidazole (MPB). Biochim. Biophys. Acta. 1499:2000;11-18
31. Wang H., Ng T.B., Ooi V.E., Liu W.K. Effects of lectins with different carbohydrate-binding specificities on hepatoma, choriocarcinoma, melanoma and osteosarcoma cell lines. Int. J. Biochem. Cell Biol. 32:2000;365-372
32. Twal W.O., Czirok A., Hegedus B., Knaak C., Chintalapudi M.R., Okagawa H., Sugi Y., Argraves W.S. Fibulin-1 suppression of fibronectin-regulated cell adhesion and motility. J. Cell Sci. 114:2001;4587-4598
33. Niles R.M., Combs R. The relationship between susceptibility to retinoic acid treatment and protein kinase C alpha expression in murine melanoma cell lines. Exp. Cell Res. 223:1996;20-28
34. Gu M., Meng K., Majerus P.W. The effect of overexpression of the protein tyrosine phosphatase PTPMEG on cell growth and on colony formation in soft agar in COS-7 cells. Proc. Natl. Acad. Sci. U. S. A. 93:1996;12980-12985
35. Zhao W., Liu H., Xu S., Entschladen F., Niggemann B., Zanker K.S., Han R. Migration and metalloproteinases determine the invasive potential of mouse melanoma cells, but not melanin and telomerase. Cancer Lett. 162:2001;S49-S55. (Suppl.)
36. Wald M., Olejar T., Sebkova V., Zadinova M., Boubelik M., Pouckova P. Mixture of trypsin, chymotrypsin and papain reduces formation of metastases and extends survival time of C57Bl6 mice with syngeneic melanoma B16. Cancer Chemother. Pharmacol. 47:2001;S16-S22. (Suppl.)
37. Hangan D., Morris V.L., Boeters L., von Ballestrem C., Uniyal S., Chan B.M. An epitope on VLA-6 (alpha6beta1) integrin involved in migration but not adhesion is required for extravasation of murine melanoma B16F1 cells in liver. Cancer Res. 57:1997;3812-3817
38. Gehlsen K.R., Hendrix M.J. In vitro assay demonstrates similar invasion profiles for B16F1 and B16F10 murine melanoma cells. Cancer Lett. 30:1986;207-212
39. Coqueret O. Linking cyclins to transcriptional control. Gene. 299:2002;35-55
40. Sutherland R.L., Musgrove E.A. Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models. Breast Cancer Res. 4:2002;14-17
41. Leygue E., Snell L., Dotzlaw H., Hole K., Hiller-Hitchcock T., Roughley P.J., Watson P.H., Murphy L.C. Expression of lumican in human breast carcinoma. Cancer Res. 58:1998;1348-1352
42. Iozzo R.V., Cohen I. Altered proteoglycan gene expression and the tumor stroma. Experientia. 49:1993;447-455
43. Santra M., Skorski T., Calabretta B., Lattime E.C., Iozzo R.V. De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. Proc. Natl. Acad. Sci. U. S. A. 92:1995;7016-7020
44. Santra M., Mann D.M., Mercer E.W., Skorski T., Calabretta B., Iozzo R.V. Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. J. Clin. Invest. 100:1997;149-157
45. Reed C.C., Gauldie J., Iozzo R.V. Suppression of tumorigenicity by adenovirus-mediated gene transfer of decorin. Oncogene. 21:2002;3688-3695
46. Funderburgh J.L., Funderburgh M.L., Mann M.M., Conrad G.W. Arterial lumican. Properties of a corneal-type keratan sulfate proteoglycan from bovine aorta. J. Biol. Chem. 266:1991;24773-24777
47. Karjalainen J.M., Eskelinen M.J., Nordling S., Lipponen P.K., Alhava E.M., Kosma V.M. Mitotic rate and S-phase fraction as prognostic factors in stage I cutaneous malignant melanoma. Br. J. Cancer. 77:1998;1917-1925
48. Hornebeck W., Emonard H., Monboisse J.C., Bellon G. Matrix-directed regulation of pericellular proteolysis and tumor progression. Semin. Cancer Biol. 12:2002;231-241
49. Ramos D.M., Berston E.D., Kramer R.H. Analysis of integrin receptors for laminin and type IV collagen on metastatic B16 melanoma cells. Cancer Res. 50:1990;728-734
50. Ruoslahti E. Structure and biology of proteoglycans. Annu. Rev. Cell Biol. 4:1988;229-255
51. Hart I.R., Birch M., Marshall J.F. Cell adhesion receptor expression during melanoma progression and metastasis. Cancer Metastasis Rev. 10:1991;115-128
52. Knutson J.R., Iida J., Fields G.B., McCarthy J.B. CD44/chondroitin sulfate proteoglycan and alpha 2 beta 1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes. Mol. Biol. Cell. 7:1996;383-396
53. Verfaillie C.M., Benis A., Iida J., McGlave P.B., McCarthy J.B. Adhesion of committed human hematopoietic progenitors to synthetic peptides from the C-terminal heparin-binding domain of fibronectin: cooperation between the integrin alpha 4 beta 1 and the CD44 adhesion receptor. Blood. 84:1994;1802-1811
54. Hurley R.W., McCarthy J.B., Wayner E.A., Verfaillie C.M. Monoclonal antibody crosslinking of the alpha 4 or beta 1 integrin inhibits committed clonogenic hematopoietic progenitor proliferation. Exp. Hematol. 25:1997;321-328
55. Huang Z. Bcl-2 family proteins as targets for anticancer drug design. Oncogene. 19:2000;6627-6631
56. Adams J.M. Ways of dying: multiple pathways to apoptosis. Genes Dev. 17:2003;2481-2495
57. Shih I.M., Herlyn M. Autocrine and paracrine roles for growth factors in melanoma. In Vivo. 8:1994;113-123
58. Tufvesson E., Westergren-Thorsson G. Tumour necrosis factor-alpha interacts with biglycan and decorin. FEBS Lett. 530:2002;124-128
59. Breckenridge D.G., Germain M., Mathai J.P., Nguyen M., Shore G.C. Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene. 22:2003;8608-8618